(650) 969-5600
Contact

Xeomin

Xeomin is a popular, FDA-approved injectable neuromodulator similar to BotoxÒ, utilized for its cosmetic and therapeutic benefits. Offered at the Palo Alto Dermatology Institute in Palo Alto, California, Xeomin is known for its efficacy in smoothing wrinkles and fine lines, providing a refreshed, youthful appearance. Unlike other botulinum toxin-based treatments, Xeomin contains no additional proteins, which may reduce the likelihood of antibody resistance, making it a valuable option for patients seeking effective anti-aging solutions.

Xeomin is a highly purified form of botulinum toxin type A. By temporarily relaxing specific facial muscles responsible for expressions that contribute to wrinkles, Xeomin helps reduce the appearance of dynamic lines, such as frown lines between the eyebrows, forehead lines, and crow’s feet. The treatment is commonly chosen by patients who want to achieve a more rejuvenated look without invasive surgery.

At Palo Alto Dermatology Institute, Xeomin is primarily used for cosmetic enhancement, helping patients address common signs of aging. The most frequent treatment areas include:

  • Glabellar Lines: Also known as “frown lines,” these lines appear between the eyebrows and can give the face an angry or tense appearance.
  • Forehead Wrinkles: These horizontal lines across the forehead often develop due to repeated expressions and aging.
  • Crow’s Feet: The fine lines around the eyes that deepen over time with expressions such as smiling or squinting.

The Xeomin injection procedure at Palo Alto Dermatology Institute is straightforward, minimally invasive, and typically completed within 10-15 minutes. After an initial consultation to understand the patient’s goals and discuss any concerns, a dermatologist will cleanse the treatment area. Using a fine needle, they will inject Xeomin into the targeted facial muscles. Patients may feel a brief pinch, but the procedure generally does not require anesthesia, though a topical numbing cream can be applied for comfort.

Following the injection, patients can resume normal activities immediately, making it an ideal lunchtime procedure. Some may experience mild redness, swelling, or bruising at the injection sites, but these effects are temporary and typically resolve within a few days.

Results from Xeomin typically become visible within 3-4 days after treatment and can last for three to four months. Patients can choose to undergo repeat treatments to maintain their refreshed appearance.

  • Quick and Convenient: Xeomin injections are a quick, in-office treatment with minimal downtime, allowing patients to resume their daily activities immediately.
  • Effective Results: Xeomin helps reduce the appearance of wrinkles and fine lines, creating a smoother, more youthful look.
  • No Additives: Unlike Botox, Xeomin contains only the active botulinum toxin ingredient, with no added proteins, which may reduce the risk of developing resistance to the treatment.
  • Natural Look: When administered by a skilled dermatologist at Palo Alto Dermatology Institute, Xeomin provides subtle results, allowing patients to retain a natural appearance without the “frozen” look sometimes associated with neuromodulators.

As with any cosmetic procedure, Xeomin has potential side effects. Common side effects include temporary redness, swelling, and bruising at the injection site. Some patients may also experience mild discomfort or tenderness shortly after treatment. Your Palo Alto Dermatology Institute dermatologist will discuss this and answer your questions during your consultation.

Xeomin and Botox are both popular injectable treatments that utilize botulinum toxin type A to temporarily relax facial muscles and reduce the appearance of fine lines and wrinkles. While they share a similar mechanism of action, there are key differences between the two that may influence a patient’s choice, depending on their individual needs and treatment goals.

Formulation: One of the main distinctions between Xeomin and Botox lies in their formulation. Xeomin contains only the pure active ingredient, botulinum toxin type A, with no additional proteins. Botox, on the other hand, includes accessory proteins in its formulation. For some patients, the absence of additional proteins in Xeomin reduces the risk of the body developing antibodies that can lead to treatment resistance over time, which could make Xeomin more effective for long-term use in certain individuals.

Onset and duration of effects: Patients report noticing effects from Xeomin slightly faster, within 3–4 days, compared to 3–7 days with Botox. The duration of results for both treatments is similar as well, typically lasting between 3–4 months, though individual results may vary based on factors like the patient’s metabolism, the area treated, and dosage used. For maintenance, patients can undergo follow-up treatments approximately every 3–4 months.

Ultimately, the choice between Xeomin and Botox may come down to individual preferences, specific aesthetic goals, and previous treatment experiences. At Palo Alto Dermatology Institute, our skilled dermatologists can help patients determine the most appropriate option based on a thorough consultation, ensuring each patient achieves optimal and satisfying results.

For patients interested in learning more about Xeomin and how it can benefit their appearance, scheduling a consultation with Palo Alto Dermatology Institute is the first step toward achieving a refreshed, revitalized look.

Call • (650) 969-5600
Request an Appointment

Schedule Consult